Cellect Biotechnology Announces the ApoGraft Bone Marrow Transplantation of First Patient in U.S.
Tel Aviv, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reflecting continued clinical progress, Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced the first ApoGraftTM transplantation in…
